Three classic combustion stages of the flame. by Lei Bai (631944)

Subjects:

Flame binarization image processing flow. by Lei Bai (631944)

Subjects:

Experimental condition of fixed oil drop volume. by Lei Bai (631944)

Subjects:

Schematic diagram of experimental injector size. by Lei Bai (631944)

Subjects:

Droplet boiling modes at different temperatures. by Lei Bai (631944)

Subjects:

Risk Classification Diagram of Hot Surface. by Lei Bai (631944)

Subjects:

Physical parameters of engine lubricating oil. by Lei Bai (631944)

Subjects:

Variation of heat flow with wall temperature. by Lei Bai (631944)

Subjects:

Innovation and night light in large and small cities. by Saul Estrin (8629173)

Nightlight densities in the lowest, around the median and the highest ranked cities in the sample and the distribution of firms in each city. by Saul Estrin (8629173)

Scheme of g-λ model with larger values λ. by Zhanfeng Fan (20390992)

“…And if the value of λ assumes larger values, the distortion in the shape of the transmitted wave is associated with the plastic deformation in the uncoupled rock mass. …”

CaMKKβ is involved in ST2-104-regulated decrease in autophagy. by Yingshi Ji (9013004)

CaMKKβ contributes to the decrease in apoptosis conferred by ST2-104. by Yingshi Ji (9013004)

Cardamonin induced apoptosis and decreased the MMP of ovarian cancer cells. by Peiguang Niu (17044532)

Five-stage speed adjustment. by Jianrong Cai (14245136)

COVID-19 epidemic curve and the timing of the restrictions for the Greater Toronto Area between February 23, 2020 and December 13, 2020. by Siyi Wang (1412581)

GI-1d-a: Comparison of estimates of people for dataset A (left bar) and B (right bar) per region. The largest discrepancies occur in areas of NE, SE and SW Germany and adjacent reg... by Isabell Schmidt (6331013)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Subjects: